|
IARS2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.26620000051992E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.046400E-04 |
| Normal-vs-Stage2 |
7.030000E-02 |
| Normal-vs-Stage3 |
3.17579999997708E-06 |
| Normal-vs-Stage4 |
1.84894999999408E-05 |
| Stage1-vs-Stage2 |
9.140200E-01 |
| Stage1-vs-Stage3 |
2.252000E-02 |
| Stage1-vs-Stage4 |
2.984000E-02 |
| Stage2-vs-Stage3 |
1.157020E-01 |
| Stage2-vs-Stage4 |
1.263650E-01 |
| Stage3-vs-Stage4 |
8.962000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.45360000003425E-06 |
| Normal-vs-AfricanAmerican |
4.05490000000563E-05 |
| Normal-vs-Asian |
6.398200E-01 |
| Caucasian-vs-AfricanAmerican |
1.949390E-01 |
| Caucasian-vs-Asian |
5.110200E-01 |
| AfricanAmerican-vs-Asian |
2.126000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.98509999946606E-08 |
| Normal-vs-Female |
5.079100E-03 |
| Male-vs-Female |
4.068200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.856300E-03 |
| Normal-vs-Age(41-60Yrs) |
3.75760000004277E-06 |
| Normal-vs-Age(61-80Yrs) |
1.961760E-04 |
| Normal-vs-Age(81-100Yrs) |
5.698900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.893000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.430600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.622800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.837000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.792800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.681600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.401000E-01 |
| Normal-vs-Grade 2 |
7.173700E-04 |
| Normal-vs-Grade 3 |
1.50106999999844E-05 |
| Normal-vs-Grade 4 |
3.15880000045787E-07 |
| Grade 1-vs-Grade 2 |
4.148400E-01 |
| Grade 1-vs-Grade 3 |
2.253400E-01 |
| Grade 1-vs-Grade 4 |
3.634300E-02 |
| Grade 2-vs-Grade 3 |
1.789950E-01 |
| Grade 2-vs-Grade 4 |
3.240200E-03 |
| Grade 3-vs-Grade 4 |
6.790200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.953200E-01 |
| Normal-vs-ccB subtype |
7.84910000328765E-08 |
| ccA subtype-vs-ccB subtype |
4.00280000001363E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.52819999998943E-06 |
| Normal-vs-N1 |
9.344400E-01 |
| N0-vs-N1 |
3.997600E-01 |
|
|
